RxDoctor Payments Data

Mina Abadeer

Foot & Ankle Surgery · Hackensack, NJNPI 1396184990

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Stryker at 27.1% of the total. Among foot & ankle surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,342in general payments, 2019–2025

Across 254 payments — averaging $84.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$6K
  • Integra Lifesciences Corporation$4K
  • Seapearl East, Inc$3K
  • Paragon 28, Inc.$2K
  • Smith+Nephew$2K
  • Musculoskeletal Transplant Foundation Inc.$1K
  • plus $4K from 32 others

What the payments were for

  • Travel & lodging$7,84837%
  • Food & beverage$12,29458%
  • Education$1,2006%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,342 in reported general payments places this provider in the 90th percentile of 542 foot & ankle surgery providers in New Jersey.

See all foot & ankle surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$305,800
Medicare patients
292
Services billed
3,218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox85$2,948
Ammonium Lactate150$2,877
Ketoconazole39$1,256
Cephalexin62$533
Diclofenac Sodium32$495
Gabapentin61$309
Mupirocin42$276
Clotrimazole30$190
Ibuprofen18$133
Doxycycline Hyclate12$119
Meloxicam35$88
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$87
Methylprednisolone13$77
Clindamycin Hcl12$76
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$53

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Hackensack

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →